Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-276,462
Closed -$22.2M 16
2019
Q2
$221K Buy
+276,462
New +$21.2M 4.1% 4
2018
Q4
Sell
-6,682
Closed -$472K 259
2018
Q3
$452K Sell
6,682
-4,249
-39% -$271K 0.71% 22
2018
Q2
$633K Sell
10,931
-11,299
-51% -$637K 0.96% 15
2018
Q1
$1.16M Sell
22,230
-21,210
-49% -$1.15M 0.79% 13
2017
Q4
$2.33M Buy
43,440
+25,958
+148% +$1.44M 1.62% 7
2017
Q3
$1.07M Buy
17,482
+13,291
+317% +$806K 0.67% 8
2017
Q2
$256K Sell
4,191
-1,887
-31% -$115K 0.24% 88
2017
Q1
$369K Buy
6,078
+2,736
+82% +$166K 0.25% 159
2016
Q4
$188K Buy
3,342
+2,123
+174% +$124K 0.19% 88
2016
Q3
$73K Buy
+1,219
New +$71.3K 0.08% 238
2016
Q2
Sell
-12,262
Closed -$619K 380
2016
Q1
$619K Buy
12,262
+6,083
+98% +$298K 0.38% 116
2015
Q4
$311K Buy
+6,179
New +$312K 0.25% 86

Other funds holding MRK

TLP Group's MRK Position: Q3 2019 in Review

TLP Group sold out of Merck (MRK) in Q3 2019, closing a stake of 276,462 shares — an estimated $22.2M sold.

TLP Group first reported a position in MRK in Q4 2015 and held it in 12 quarters. The position peaked at $2.33M in Q4 2017. 2,305 funds tracked by Wall St. Rank hold MRK as of Q3 2019.

  • TLP Group reported no remaining Merck position as of Q3 2019 after selling out during the quarter.
  • TLP Group sold 276,462 Merck shares in Q3 2019, an estimated $22.2M.
  • TLP Group first reported a position in Merck in Q4 2015 and held it in 12 quarters.
  • TLP Group's Merck position peaked at $2.33M in Q4 2017.
  • 2,305 funds tracked by Wall St. Rank held Merck as of Q3 2019.

Based on TLP Group's 13F filing for Q3 2019, filed 11 Oct 2019.